203 related articles for article (PubMed ID: 16962577)
21. Discovery of the imidazo[1,5-a][1,2,4]-triazolo[1,5-d][1,4]benzodiazepine scaffold as a novel, potent and selective GABA(A) alpha5 inverse agonist series.
Achermann G; Ballard TM; Blasco F; Broutin PE; Büttelmann B; Fischer H; Graf M; Hernandez MC; Hilty P; Knoflach F; Koblet A; Knust H; Kurt A; Martin JR; Masciadri R; Porter RH; Stadler H; Thomas AW; Trube G; Wichmann J
Bioorg Med Chem Lett; 2009 Oct; 19(19):5746-52. PubMed ID: 19726184
[TBL] [Abstract][Full Text] [Related]
22. In vivo binding of beta-carbolines in mice: regional differences and correlation of occupancy to pharmacological effects.
Potier MC; Prado de Carvalho L; Dodd RH; Besselievre R; Rossier J
Mol Pharmacol; 1988 Aug; 34(2):124-8. PubMed ID: 2842651
[TBL] [Abstract][Full Text] [Related]
23. Regional differences in the inhibition of mouse in vivo [3H]Ro 15-1788 binding reflect selectivity for alpha 1 versus alpha 2 and alpha 3 subunit-containing GABAA receptors.
Atack JR; Smith AJ; Emms F; McKernan RM
Neuropsychopharmacology; 1999 Mar; 20(3):255-62. PubMed ID: 10063485
[TBL] [Abstract][Full Text] [Related]
24. RO4938581, a novel cognitive enhancer acting at GABAA alpha5 subunit-containing receptors.
Ballard TM; Knoflach F; Prinssen E; Borroni E; Vivian JA; Basile J; Gasser R; Moreau JL; Wettstein JG; Buettelmann B; Knust H; Thomas AW; Trube G; Hernandez MC
Psychopharmacology (Berl); 2009 Jan; 202(1-3):207-23. PubMed ID: 18936916
[TBL] [Abstract][Full Text] [Related]
25. Bidirectional effects of benzodiazepine binding site ligands in the passive avoidance task: differential antagonism by flumazenil and beta-CCt.
Savić MM; Obradović DI; Ugresić ND; Cook JM; Yin W; Bokonjić DR
Behav Brain Res; 2005 Mar; 158(2):293-300. PubMed ID: 15698896
[TBL] [Abstract][Full Text] [Related]
26. Anxiolytic-like effects of 8-acetylene imidazobenzodiazepines in a rhesus monkey conflict procedure.
Fischer BD; Licata SC; Edwankar RV; Wang ZJ; Huang S; He X; Yu J; Zhou H; Johnson EM; Cook JM; Furtmüller R; Ramerstorfer J; Sieghart W; Roth BL; Majumder S; Rowlett JK
Neuropharmacology; 2010 Dec; 59(7-8):612-8. PubMed ID: 20727364
[TBL] [Abstract][Full Text] [Related]
27. Role of GABAA alpha5-containing receptors in ethanol reward: the effects of targeted gene deletion, and a selective inverse agonist.
Stephens DN; Pistovcakova J; Worthing L; Atack JR; Dawson GR
Eur J Pharmacol; 2005 Dec; 526(1-3):240-50. PubMed ID: 16253225
[TBL] [Abstract][Full Text] [Related]
28. A single amino acid residue on the alpha(5) subunit (Ile215) is essential for ligand selectivity at alpha(5)beta(3)gamma(2) gamma-aminobutyric acid(A) receptors.
Strakhova MI; Harvey SC; Cook CM; Cook JM; Skolnick P
Mol Pharmacol; 2000 Dec; 58(6):1434-40. PubMed ID: 11093783
[TBL] [Abstract][Full Text] [Related]
29. Alpha2-containing GABA(A) receptors are involved in mediating stimulant effects of cocaine.
Morris HV; Dawson GR; Reynolds DS; Atack JR; Rosahl TW; Stephens DN
Pharmacol Biochem Behav; 2008 Jul; 90(1):9-18. PubMed ID: 18358520
[TBL] [Abstract][Full Text] [Related]
30. Preclinical and clinical pharmacology of the GABAA receptor alpha5 subtype-selective inverse agonist alpha5IA.
Atack JR
Pharmacol Ther; 2010 Jan; 125(1):11-26. PubMed ID: 19770002
[TBL] [Abstract][Full Text] [Related]
31. PWZ-029, a compound with moderate inverse agonist functional selectivity at GABA(A) receptors containing alpha5 subunits, improves passive, but not active, avoidance learning in rats.
Savić MM; Clayton T; Furtmüller R; Gavrilović I; Samardzić J; Savić S; Huck S; Sieghart W; Cook JM
Brain Res; 2008 May; 1208():150-9. PubMed ID: 18394590
[TBL] [Abstract][Full Text] [Related]
32. Identification of amino acid residues responsible for the alpha5 subunit binding selectivity of L-655,708, a benzodiazepine binding site ligand at the GABA(A) receptor.
Casula MA; Bromidge FA; Pillai GV; Wingrove PB; Martin K; Maubach K; Seabrook GR; Whiting PJ; Hadingham KL
J Neurochem; 2001 Apr; 77(2):445-51. PubMed ID: 11299307
[TBL] [Abstract][Full Text] [Related]
33. The discovery and unique pharmacological profile of RO4938581 and RO4882224 as potent and selective GABAA alpha5 inverse agonists for the treatment of cognitive dysfunction.
Knust H; Achermann G; Ballard T; Buettelmann B; Gasser R; Fischer H; Hernandez MC; Knoflach F; Koblet A; Stadler H; Thomas AW; Trube G; Waldmeier P
Bioorg Med Chem Lett; 2009 Oct; 19(20):5940-4. PubMed ID: 19762240
[TBL] [Abstract][Full Text] [Related]
34. Imidazo[1,5-a][1,2,4]-triazolo[1,5-d][1,4]benzodiazepines as potent and highly selective GABAA alpha5 inverse agonists with potential for the treatment of cognitive dysfunction.
Buettelmann B; Ballard TM; Gasser R; Fischer H; Hernandez MC; Knoflach F; Knust H; Stadler H; Thomas AW; Trube G
Bioorg Med Chem Lett; 2009 Oct; 19(20):5958-61. PubMed ID: 19740657
[TBL] [Abstract][Full Text] [Related]
35. Selective GABAA alpha5 benzodiazepine inverse agonist antagonizes the neurobehavioral actions of alcohol.
Cook JB; Foster KL; Eiler WJ; McKay PF; Woods J; Harvey SC; Garcia M; Grey C; McCane S; Mason D; Cummings R; Li X; Cook JM; June HL
Alcohol Clin Exp Res; 2005 Aug; 29(8):1390-401. PubMed ID: 16131846
[TBL] [Abstract][Full Text] [Related]
36. GABA(A) receptors containing (alpha)5 subunits in the CA1 and CA3 hippocampal fields regulate ethanol-motivated behaviors: an extended ethanol reward circuitry.
June HL; Harvey SC; Foster KL; McKay PF; Cummings R; Garcia M; Mason D; Grey C; McCane S; Williams LS; Johnson TB; He X; Rock S; Cook JM
J Neurosci; 2001 Mar; 21(6):2166-77. PubMed ID: 11245701
[TBL] [Abstract][Full Text] [Related]
37. GABAA receptor subtype-selective modulators. I. α2/α3-selective agonists as non-sedating anxiolytics.
Atack JR
Curr Top Med Chem; 2011; 11(9):1176-202. PubMed ID: 21050172
[TBL] [Abstract][Full Text] [Related]
38. Contribution of specific binding to the central benzodiazepine site to the brain concentrations of two novel benzodiazepine site ligands.
Pike A; Cook SM; Watt AP; Scott-Stevens P; Rosahl TW; McKernan RM; Pym LJ; Guiblin A; Moyes C; Sohal B; Atack JR
Biopharm Drug Dispos; 2007 Sep; 28(6):275-82. PubMed ID: 17570124
[TBL] [Abstract][Full Text] [Related]
39. 6,2'-Dihydroxyflavone, a subtype-selective partial inverse agonist of GABAA receptor benzodiazepine site.
Wang F; Xu Z; Yuen CT; Chow CY; Lui YL; Tsang SY; Xue H
Neuropharmacology; 2007 Sep; 53(4):574-82. PubMed ID: 17681556
[TBL] [Abstract][Full Text] [Related]
40. Imidazo[1,2-b][1,2,4]triazines as alpha2/alpha3 subtype selective GABA A agonists for the treatment of anxiety.
Jennings AS; Lewis RT; Russell MG; Hallett DJ; Street LJ; Castro JL; Atack JR; Cook SM; Lincoln R; Stanley J; Smith AJ; Reynolds DS; Sohal B; Pike A; Marshall GR; Wafford KA; Sheppard WF; Tye SJ
Bioorg Med Chem Lett; 2006 Mar; 16(6):1477-80. PubMed ID: 16386900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
